A. Relationship of Vaccines and Various Diseases |
|
1. Allergy
and Asthma |
|
|
Abstract |
Intussusception among infants given an oral rotavirus
vaccine. Murphy TV, Gargiullo PM, Massoudi MS, et al. N.Engl.J.Med.
2001; 344: 564-572. |
|
|
Abstract |
Effects of diphtheria-tetanus-pertussis or tetanus
vaccination on allergies and allergy-related respiratory
symptoms among children and adolescents in the United
States. Hurwitz EL, Morgenstern H. J.Manipulative
Physiol Ther. 2000; 23: 81-90. |
|
|
Abstract |
Does influenza vaccination exacerbate asthma? Analysis of
a large cohort of children with asthma. Vaccine Safety
Datalink Team. Kramarz P, DeStefano F, Gargiullo PM, et
al. Arch.Fam.Med. 2000; 9: 617-623. |
|
|
Abstract |
Can immunization affect the development of allergy? Pershagen
G. Pediatr.Allergy Immunol. 2000; 11 Suppl 13:
26-28. |
| |
|
Abstract |
Booster immunization of children with an acellular
pertussis vaccine enhances Th2 cytokine production and serum
IgE responses against pertussis toxin but not against common
allergens. Ryan EJ, Nilsson L, Kjellman N, et al. Clin.Exp.Immunol.
2000; 121: 193-200. |
|
|
Abstract |
[The effect of DPT and BCG vaccinations on atopic
disorders]. Yoneyama H, Suzuki M, Fujii K, et al. Arerugi
2000; 49: 585-592. |
|
|
Abstract |
Genetic and environmental factors contributing to the
onset of allergic disorders. Parronchi P, Brugnolo F,
Sampognaro S, et al. Int.Arch.Allergy Immunol. 2000;
121: 2-9. |
|
|
Abstract |
What is a safe vaccine? Lonergan G, Rivest P. Vaccine
2000; 19: 1. |
|
|
Abstract |
Postlicensure safety surveillance for varicella vaccine. Wise
RP, Salive ME, Braun MM, et al. JAMA 2000; 284:
1271-1279. |
|
|
Abstract |
Pertussis vaccination and wheezing illnesses in young
children: prospective cohort study. The Longitudinal Study
of Pregnancy and Childhood Team. Henderson J, North K,
Griffiths M, et al. BMJ 1999; 318:
1173-1176. |
|
|
Abstract |
A clinical analysis of gelatin allergy and determination
of its causal relationship to the previous administration of
gelatin-containing acellular pertussis vaccine combined with
diphtheria and tetanus toxoids. Nakayama T, Aizawa C,
Kuno-Sakai H. J.Allergy Clin.Immunol. 1999; 103:
321-325. |
|
|
Abstract |
Pertussis adjuvant prolongs intestinal hypersensitivity. Kosecka
U, Berin MC, Perdue MH. Int.Arch.Allergy Immunol.
1999; 119: 205-211. |
|
|
Abstract |
A randomized controlled trial of the effect of pertussis
vaccines on atopic disease. Nilsson L, Kjellman NI,
Bjorksten B. Arch.Pediatr.Adolesc.Med. 1998; 152:
734-738. |
|
|
Abstract |
Early childhood infection and atopic disorder. Farooqi
IS, Hopkin JM. Thorax 1998; 53: 927-932. |
|
|
Abstract |
Give us this day our daily germs. Rook GA, Stanford
JL. Immunol.Today 1998; 19: 113-116. |
|
|
Abstract |
Is infant immunization a risk factor for childhood asthma
or allergy? Kemp T, Pearce N, Fitzharris P, et al. Epidemiology
1997; 8: 678-680. |
|
|
Abstract |
Lack of association between pertussis vaccination and
symptoms of asthma and allergy. Nilsson L, Kjellman NI,
Storsaeter J, et al. JAMA 1996; 275: 760. |
|
|
Abstract |
Pertussis vaccination and asthma: is there a link? Odent
MR, Culpin EE, Kimmel T. JAMA 1994; 272:
592-593. |
|
|
Abstract |
Adverse Events Associated with Childhood Vaccines:
Evidence Bearing on Causality. Vaccine Safety
Committee IOM. Washington, D.C.: National Academy Press,
1994. |
|
|
Abstract |
Adverse events following pertussis and rubella vaccines.
Summary of a report of the Institute of Medicine. Howson
CP, Fineberg HV. JAMA 1992; 267: 392-396. |
|
|
Abstract |
Adverse Effects of Pertussis and Rubella Vaccines: A
Report of the Committee to review the Adverse Consequences
of Pertussis and Rubella Vaccines. Committee to
Review the Adverse Consequences of Pertussis and Rubella
Vaccines IOM. National Academy Press, Washington D.C., 1991. |
|
|
Abstract |
Pertussis booster vaccination and immediate
hypersensitivity. Gifford CG, Gonsior EC, Villacorte GV,
et al. Ann.Allergy 1985; 54: 483-485. |
|
2. Autism |
|
|
Abstract |
Measles-Mumps-Rubella Vaccine and Autism.
Immunization Safety Review Committee IOM. Kathleen Stratton,
Alicia Gable Padma Shetty and Marie McCormick Editors. 2001.
Washington, D.C., National Academy Press. |
|
|
Abstract |
Endangering Public Health. The Washington Post,
A20. 2001. Washington D.C. |
|
|
Abstract |
Thimerosal-containing Vaccines and Neurodevelopmental
Disorders. Immunization Safety Review Committee IOM.
Kathleen Stratton, Alicia Gable and Marie McCormick Editors.
2001. Washington, D.C., National Academy Press. |
|
|
Abstract |
Time trends in autism and in MMR immunization coverage in
California. Dales L, Hammer SJ, Smith NJ. JAMA
2001; 285: 1183-1185. |
|
|
Abstract |
Mumps, measles, and rubella vaccine and the incidence of
autism recorded by general practitioners: a time trend
analysis. Kaye JA, Mar Melero-Montes M, Jick H. BMJ
2001; 322: 460-463. |
|
|
Abstract |
Measles-mumps-rubella vaccine and autistic spectrum
disorder: report from the New Challenges in Childhood
Immunizations Conference convened in Oak Brook, Illinois,
June 12-13, 2000. Halsey NA, Hyman SL. Pediatrics
2001; 107: E84. |
|
|
Abstract |
On autism: Its prevalence, diagnosis, causes and
treatment. Gleberzon B, Rosenberg-Gleberzon A. Topics
in Clinical Chiropractic 2001; 8: 42-57. |
|
|
Abstract |
Autism: Present Challenges, Future Needs--Why The
Increased Rates? 106-180. 2000. Washington D.C.,
U.S. Government Printing Office. |
|
|
Abstract |
Measles-mumps-rubella immunisation, autism and
inflammatory bowel disease: update. Amin J, Wong M. Commun.Dis.Intell.
1999; 23: 222. |
|
3. Central
Nervous System Sequelae and Sudden Infant Death Syndrome |
|
|
Abstract |
The risk of seizures after receipt of whole-cell
pertussis or measles, mumps, and rubella vaccine. Barlow
WE, Davis RL, Glasser JW, et al. N.Engl.J.Med. 2001;
345: 656-661. |
|
|
Abstract |
Hepatitis B vaccine and central nervous system
demyelinating diseases. Viral Hepatitis Prevention Board. Halsey
NA, Duclos P, Van Damme P, et al. Pediatr.Infect.Dis.J.
1999; 18: 23-24. |
|
|
Abstract |
The protective effect of immunisation against diphtheria,
pertussis and tetanus (DPT) in relation to sudden infant
death syndrome. Essery SD, Raza MW, Zorgani A, et al. FEMS
Immunol.Med.Microbiol. 1999; 25: 183-192. |
|
|
Abstract |
Pertussis immunization: An update. Morgan LG. J
Can Chiropr Assoc 1997; 41: 86-90. |
|
|
Abstract |
Risk of serious acute neurological illness after
immunization with diphtheria-tetanus-pertussis vaccine. A
population-based case-control study. Gale JL, Thapa PB,
Wassilak SG, et al. JAMA 1994; 271: 37-41. |
|
|
Abstract |
Risk of sudden infant death syndrome after immunization
with the diphtheria-tetanus-pertussis vaccine. Griffin
MR, Ray WA, Livengood JR, et al. N.Engl.J.Med. 1988;
319: 618-623. |
|
4. Diabetes |
|
|
Abstract |
Childhood immunizations and type 1 diabetes: summary of
an Institute for Vaccine Safety Workshop. The Institute for
Vaccine Safety Diabetes Workshop Panel. Pediatr.Infect.Dis.J.
1999; 18: 217-222. |
|
|
Abstract |
No evidence that vaccines cause insulin dependent
diabetes mellitus. Jefferson T, Demicheli V. J.Epidemiol.Community
Health 1998; 52: 674-675. |
|
|
|
The timing of pediatric immunization and the risk of
insulin-dependant diabetes mellitus. Classen JB, Classen
DC. Infectious Diseases in Clinical Practice 1997; 6:
449-454. |
|
|
Abstract |
The timing of immunization affects the development of
diabetes in rodents. Classen JB. Autoimmunity
1996; 24: 137-145. |
|
5. Multiple
Sclerosis |
|
|
Abstract |
Vaccinations and the risk of relapse in multiple
sclerosis. Vaccines in Multiple Sclerosis Study Group. Confavreux
C, Suissa S, Saddier P, et al. N.Engl.J.Med. 2001;
344: 319-326. |
|
|
Abstract |
Hepatitis B vaccination and the risk of multiple
sclerosis. Ascherio A, Zhang SM, Hernan MA, et al. N.Engl.J.Med.
2001; 344: 327-332. |
|
6.
Other/General |
|
|
Abstract |
Commentary on Potential Risk From Thimerosal for Infants
. Halsey N. Institute for Vaccine Safety, Johns Hopkins
University. 2001. |
|
|
Abstract |
Update: vaccine side effects, adverse reactions,
contraindications, and precautions. Recommendations of the
Advisory Committee on Immunization Practices (ACIP). CDC.
MMWR Recomm.Rep. 1996; 45: 1-35. |
|
|
Abstract |
Adverse events associated with childhood vaccines other
than pertussis and rubella. Summary of a report from the
Institute of Medicine. Stratton KR, Howe CJ, Johnston RB,
Jr. JAMA 1994; 271: 1602-1605. |
B. Vaccine Adverse Event Reporting System (VAERS), and
reviews/commentary/discussions of vaccine safety and
risk. |
|
|
Abstract |
Safety considerations for new vaccine development. Ellenberg
SS. Pharmacoepidemiol.Drug Saf 2001; 10:
411-415. |
|
|
Abstract |
Vaccine safety: risk communication--a global perspective.
Dittmann S. Vaccine 2001; 19: 2446-2456. |
|
|
Abstract |
Conflict of interest taints vaccine approval process,
charges US report. McCarthy M. Lancet 2000; 356:
838. |
|
|
Abstract |
Withdrawal of rotavirus vaccine recommendation. CDC. MMWR
Morb.Mortal.Wkly.Rep. 1999; 48: 1007. |
|
|
Abstract |
An overview of the vaccine adverse event reporting system
(VAERS) as a surveillance system. VAERS Working Group. Singleton
JA, Lloyd JC, Mootrey GT, et al. Vaccine 1999; 17:
2908-2917. |
|
|
Abstract |
Vaccination and its adverse effects: real or perceived.
Society should think about means of linking exposure to
potential long term effect. Jefferson T. BMJ
1998; 317: 159-160. |
